Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2009 2
2010 2
2015 2
2017 1
2018 2
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Validation of ion channel targets.
Gerlach AC, Antonio BM. Gerlach AC, et al. Channels (Austin). 2015;9(6):376-9. doi: 10.1080/19336950.2015.1081725. Epub 2015 Nov 10. Channels (Austin). 2015. PMID: 26556675 Free PMC article. Review.
Personalized medicine: Vinpocetine to reverse effects of GABRB3 mutation.
Billakota S, Andresen JM, Gay BC, Stewart GR, Fedorov NB, Gerlach AC, Devinsky O. Billakota S, et al. Among authors: gerlach ac. Epilepsia. 2019 Dec;60(12):2459-2465. doi: 10.1111/epi.16394. Epub 2019 Nov 22. Epilepsia. 2019. PMID: 31755996 Free PMC article.
Discovery of a Series of Indazole TRPA1 Antagonists.
Pryde DC, Marron BE, West CW, Reister S, Amato G, Yoger K, Antonio B, Padilla K, Cox PJ, Turner J, Warmus JS, Swain NA, Omoto K, Mahoney JH, Gerlach AC. Pryde DC, et al. Among authors: gerlach ac. ACS Med Chem Lett. 2017 May 18;8(6):666-671. doi: 10.1021/acsmedchemlett.7b00140. eCollection 2017 Jun 8. ACS Med Chem Lett. 2017. PMID: 28626530 Free PMC article.
TRPA1 ankyrin repeat six interacts with a small molecule inhibitor chemotype.
Tseng WC, Pryde DC, Yoger KE, Padilla KM, Antonio BM, Han S, Shanmugasundaram V, Gerlach AC. Tseng WC, et al. Among authors: gerlach ac. Proc Natl Acad Sci U S A. 2018 Nov 27;115(48):12301-12306. doi: 10.1073/pnas.1808142115. Epub 2018 Nov 14. Proc Natl Acad Sci U S A. 2018. PMID: 30429323 Free PMC article.
A comprehensive approach to identifying repurposed drugs to treat SCN8A epilepsy.
Atkin TA, Maher CM, Gerlach AC, Gay BC, Antonio BM, Santos SC, Padilla KM, Rader J, Krafte DS, Fox MA, Stewart GR, Petrovski S, Devinsky O, Might M, Petrou S, Goldstein DB. Atkin TA, et al. Among authors: gerlach ac. Epilepsia. 2018 Apr;59(4):802-813. doi: 10.1111/epi.14037. Epub 2018 Mar 25. Epilepsia. 2018. PMID: 29574705
A novel selective and orally bioavailable Nav 1.8 channel blocker, PF-01247324, attenuates nociception and sensory neuron excitability.
Payne CE, Brown AR, Theile JW, Loucif AJ, Alexandrou AJ, Fuller MD, Mahoney JH, Antonio BM, Gerlach AC, Printzenhoff DM, Prime RL, Stockbridge G, Kirkup AJ, Bannon AW, England S, Chapman ML, Bagal S, Roeloffs R, Anand U, Anand P, Bungay PJ, Kemp M, Butt RP, Stevens EB. Payne CE, et al. Among authors: gerlach ac. Br J Pharmacol. 2015 May;172(10):2654-70. doi: 10.1111/bph.13092. Epub 2015 Apr 10. Br J Pharmacol. 2015. PMID: 25625641 Free PMC article.
11 results